Literature DB >> 16555472

Effect of sucrose and saturated-fat diets on mRNA levels of genes limiting muscle fatty acid and glucose supply in rats.

Andreu Ferrer-Martínez1, Mario Marotta, Marco Turini, Katherine Macé, Anna M Gómez-Foix.   

Abstract

In this study, we examined whether the increased availability of lipids in blood resulting from two types of diet manipulation regulated metabolic gene expression in the skeletal muscle of rats. Feeding for 4 wk on an isocaloric-sucrose or a hypercaloric-fat diet increased plasma TAG in the fed condition by increments of 70 and 40%, respectively, and increased fasting insulinemia (approximately 3-fold) compared with a starch diet. The fat diet impaired glucose tolerance and caused obesity, whereas sucrose-fed rats maintained their normal weight. We analyzed the expression of genes that regulate the exogenous FA supply (LPL, FAT/CD36, FATP1), synthesis (ACC1), glucose (GLUT4, GLUT1, HK2, GFAT1, glycogen phosphorylase) or glycerol (glycerol kinase) provision, or substrate choice for oxidation (PDK4) in gastrocnemius and soleus muscles at the end of the glucose tolerance test. LPL, FAT/CD36, FATP1, PDK4, and GLUT4 mRNA as well as glycogen phosphorylase and glycerol kinase activity levels in both muscles were unchanged by the diets. Increased mRNA levels of GLUT1 (1.6- and 2.6-fold, respectively) and GFAT1 (about 1.7-fold) in gastrocnemius, and of ACC1 (about 1.5-fold) in soleus, were found in both the sucrose and fat groups. In the fat group, HK2 mRNA was also higher (1.8-fold) in the gastrocnemius. Both sucrose and saturated-fat diets prompted hyperinsulinemia and hyperlipemia in rats. These metabolic disturbances did not alter the expression of LPL, FAT/CD36, FATP1, PDK4, and GLUT4 genes or glycogen phosphorylase and glycerol kinase activity levels in either analyzed muscle. Instead, they were linked to the coordinated upregulation in gastrocnemius of genes that govern glucose uptake and the hexosamine pathway, namely, GLUT1 and GFAT1, which might contribute to insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16555472     DOI: 10.1007/s11745-006-5070-1

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  47 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4: protein in muscle from patients with acanthosis nigricans and severe insulin resistance.

Authors:  C A Stuart; G Wen; M E Williamson; J Jiang; C R Gilkison; S J Blackwell; M Nagamani; A A Ferrando
Journal:  Metabolism       Date:  2001-07       Impact factor: 8.694

3.  Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance.

Authors:  L F Hebert; M C Daniels; J Zhou; E D Crook; R L Turner; S T Simmons; J L Neidigh; J S Zhu; A D Baron; D A McClain
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Long-term hypertriglyceridemia and glucose intolerance in rats fed chronically an isocaloric sucrose-rich diet.

Authors:  R A Gutman; M Z Basílico; C A Bernal; A Chicco; Y B Lombardo
Journal:  Metabolism       Date:  1987-11       Impact factor: 8.694

5.  The effects of hyperinsulinemia and hyperglycemia on GLUT4 and hexokinase II mRNA and protein in rat skeletal muscle and adipose tissue.

Authors:  C Postic; A Leturque; F Rencurel; R L Printz; C Forest; D K Granner; J Girard
Journal:  Diabetes       Date:  1993-06       Impact factor: 9.461

6.  The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance.

Authors:  Mary E Rinella; Richard M Green
Journal:  J Hepatol       Date:  2004-01       Impact factor: 25.083

7.  Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle.

Authors:  J M Ren; B A Marshall; E A Gulve; J Gao; D W Johnson; J O Holloszy; M Mueckler
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

8.  Fiber type- and fatty acid composition-dependent effects of high-fat diets on rat muscle triacylglyceride and fatty acid transporter protein-1 content.

Authors:  Mario Marotta; Andreu Ferrer-Martnez; Josep Parnau; Marco Turini; Katherine Macé; Anna M Gómez Foix
Journal:  Metabolism       Date:  2004-08       Impact factor: 8.694

Review 9.  Sugars, hypertriglyceridemia, and cardiovascular disease.

Authors:  Susan K Fried; Salome P Rao
Journal:  Am J Clin Nutr       Date:  2003-10       Impact factor: 7.045

10.  Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid.

Authors:  L H Storlien; A B Jenkins; D J Chisholm; W S Pascoe; S Khouri; E W Kraegen
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

View more
  3 in total

1.  Arachidonic acid induces acetyl-CoA carboxylase 1 expression via activation of CREB1.

Authors:  Yin Peng; Ting Lei; Jihong Yuan; Xiaodong Chen; Qinqiang Long; Jian Zhang; Jian Zhan; Peng Lei; Bin Feng; Zaiqing Yang
Journal:  Endocrine       Date:  2009-10-20       Impact factor: 3.633

2.  Effects of aging and calorie restriction on rat skeletal muscle glycogen synthase and glycogen phosphorylase.

Authors:  Marta Montori-Grau; Robin Minor; Carles Lerin; Joanne Allard; Celia Garcia-Martinez; Rafael de Cabo; Anna M Gómez-Foix
Journal:  Exp Gerontol       Date:  2009-03-31       Impact factor: 4.032

3.  Involvement of gut microbial fermentation in the metabolic alterations occurring in n-3 polyunsaturated fatty acids-depleted mice.

Authors:  Barbara D Pachikian; Audrey M Neyrinck; Laurence Portois; Fabienne C De Backer; Florence M Sohet; Myrjam Hacquebard; Yvon A Carpentier; Patrice D Cani; Nathalie M Delzenne
Journal:  Nutr Metab (Lond)       Date:  2011-06-27       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.